Literature DB >> 3678132

Growth allometry of the organs in giant transgenic mice.

B T Shea1, R E Hammer, R L Brinster.   

Abstract

We have analyzed the absolute and relative (allometric) growth of a series of internal organs in giant transgenic (MTrGH) and littermate control mice to determine the general and organ-specific effects of the altered hormonal environment on growth in these rodents. Comparison of cross-sectional growth allometries of organ weights and external body dimensions between the two samples was based on analyses of covariance. We report significantly increased growth in all of the organs and measurements examined except for the brain. Coefficients of growth allometry differ significantly from isometric values in a number of cases, and thus, the adult transgenic mice exhibit body proportions different from those of the adult controls. Most of these shape differences reflect general allometric size increase, but the liver and spleen of the transgenics undergo special enlargement or growth. These results indicate that the primary effect of elevated GH and IGF-I levels is increased overall growth, but in the relative proportions set by the intrinsic controls of individual organs and body regions.

Entities:  

Mesh:

Year:  1987        PMID: 3678132     DOI: 10.1210/endo-121-6-1924

Source DB:  PubMed          Journal:  Endocrinology        ISSN: 0013-7227            Impact factor:   4.736


  25 in total

1.  Differences between brain mass and body weight scaling to height: potential mechanism of reduced mass-specific resting energy expenditure of taller adults.

Authors:  Steven B Heymsfield; Thamrong Chirachariyavej; Im Joo Rhyu; Chulaporn Roongpisuthipong; Moonseong Heo; Angelo Pietrobelli
Journal:  J Appl Physiol (1985)       Date:  2008-11-13

Review 2.  The role of liver-derived insulin-like growth factor-I.

Authors:  Claes Ohlsson; Subburaman Mohan; Klara Sjögren; Asa Tivesten; Jörgen Isgaard; Olle Isaksson; John-Olov Jansson; Johan Svensson
Journal:  Endocr Rev       Date:  2009-07-09       Impact factor: 19.871

3.  Differential in vivo activities of bovine growth hormone analogues.

Authors:  J Kopchick; X Z Chen; Y Li; R W Steger; J S Yun; T E Wagner; A Bartke
Journal:  Transgenic Res       Date:  1998-01       Impact factor: 2.788

4.  The analysis of ontogenetic trajectories: when a change in size or shape is not heterochrony.

Authors:  S H Rice
Journal:  Proc Natl Acad Sci U S A       Date:  1997-02-04       Impact factor: 11.205

Review 5.  A model for tissue-specific inducible insulin-like growth factor-I (IGF-I) inactivation to determine the physiological role of liver-derived IGF-I.

Authors:  Klara Sjögren; John-Olov Jansson; Olle G P Isaksson; Claes Ohlsson
Journal:  Endocrine       Date:  2002-12       Impact factor: 3.633

6.  Liver-derived insulin-like growth factor I (IGF-I) is the principal source of IGF-I in blood but is not required for postnatal body growth in mice.

Authors:  K Sjögren; J L Liu; K Blad; S Skrtic; O Vidal; V Wallenius; D LeRoith; J Törnell; O G Isaksson; J O Jansson; C Ohlsson
Journal:  Proc Natl Acad Sci U S A       Date:  1999-06-08       Impact factor: 11.205

7.  Actions and interactions of growth hormone and insulin-like growth factor-II: body and organ growth of transgenic mice.

Authors:  A Blackburn; A Schmitt; P Schmidt; R Wanke; W Hermanns; G Brem; E Wolf
Journal:  Transgenic Res       Date:  1997-05       Impact factor: 2.788

Review 8.  Hormonal control of aging in rodents: the somatotropic axis.

Authors:  Holly M Brown-Borg
Journal:  Mol Cell Endocrinol       Date:  2008-07-11       Impact factor: 4.102

9.  Systemic overexpression of growth hormone (GH) in transgenic FVB/N inbred mice: an optimized model for holistic studies of molecular mechanisms underlying GH-induced kidney pathology.

Authors:  Dagmar C von Waldthausen; Marlon R Schneider; Ingrid Renner-Müller; Dirk N Rauleder; Nadja Herbach; Bernhard Aigner; Rüdiger Wanke; Eckhard Wolf
Journal:  Transgenic Res       Date:  2007-12-20       Impact factor: 2.788

10.  Progressive glomerulosclerosis develops in transgenic mice chronically expressing growth hormone and growth hormone releasing factor but not in those expressing insulinlike growth factor-1.

Authors:  T Doi; L J Striker; C Quaife; F G Conti; R Palmiter; R Behringer; R Brinster; G E Striker
Journal:  Am J Pathol       Date:  1988-06       Impact factor: 4.307

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.